Abiopharma

Hologic - Hologic’s AI-Powered Mammography Technology Flagged a Third of Breast Cancer Cases Initially Interpreted as Negative in Study of 7,500 Screening Exams

Hologic’s AI-Powered Mammography Technology Flagged a Third of Breast Cancer Cases Initially Interpreted as Negative in Study of 7,500 Screening Exams

Cellectar Biosciences Announces Strategic Supply Agreement with Ionetix for Actinium-225 and Astatine-211 to Advance Targeted Alpha Therapies

A New Press Release from Elicio Therapeutics

Revvity - Revvity Introduces Signals Xynthetica, an AI-Augmented Design Platform for Molecular and Materials Discovery

Natera - I-SPY 2 Publication in Nature Communications ShowsSignatera™ Can Predict Treatment Response and Recurrence Risk in Early-Stage Breast Cancer

NexGelRx Receives Additional Investment from Eric Gruntfest of Diesis Holdings, LLC and Appoints Him as Board Observer and Strategic Advisor

Zynex Financial Restructuring Puts Company on Path to Long-Term Success

Humacyte Announces Credit Facility of Up to $77.5 Million with Avenue Capital

Lipocines PPD Phase 3 Study (LPCN 1154) Hits 80% Enrollment Milestone